Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when MAZE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsMaze Therapeutics reports Q1 2026 financial results
Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read
Key Changes
-
medium
Company issued press release with Q1 2026 financial results for quarter ended March 31, 2026. Actual financial figures are in the press release attachment, not in the 8-K body.
Item 2.02 verify on EDGAR →
Summary
Maze Therapeutics filed an 8-K on May 12, 2026 to announce its first quarter financial results for the period ended March 31, 2026. The filing is procedural in nature, serving only to attach a press release (Exhibit 99.1) that contains the actual financial data and management commentary. The 8-K document itself provides no substantive financial information or narrative discussion.
For retail investors, this is a routine quarterly disclosure. The key takeaway is that Q1 results have been released, but investors must review the separate press release to understand the company's financial performance, cash position, and any updates to clinical programs or business strategy. Watch for analyst reactions and management guidance in the coming days.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Maze Therapeutics disclosed Q1 2026 financial results via press release on May 12, 2026.
Added in current filing · verify on EDGAR →
On May 12, 2026, Maze Therapeutics Inc. (the “Company”) issued a press release reporting its financial results for the first quarter ended March 31, 2026.
The company announced its financial results for the quarter ended March 31, 2026 through a press release. The 8-K itself does not contain the actual financial figures, which are provided in the attached press release exhibit.
Event · Item 9.01 — Financial Statements and Exhibits
Maze Therapeutics filed an 8-K attaching a press release announcing financial results dated May 12, 2026.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Press Release announcing financial results, dated May 12, 2026.
The company filed an 8-K to announce the attachment of a press release disclosing financial results. The 8-K itself contains no substantive financial data or narrative; it simply references Exhibit 99.1, which is the press release. Without access to the exhibit content, no material financial details can be extracted from this filing.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify